The German company Cytoimmun is a world leader in providing prognostic markers for HPV- induced cervical carcinoma.   The products are designed to help  predict simply and reliably whether a woman's HPV infection will result in the development of tumors or not. This technology is used by leading pathologists and cytologists on the basis of extensive clinical studies.

For more information, please visit the Cytoimmun Website or e-mail us.